# Complete Reference List

## Category 1: Stroke scRNAseq & Multi-Omics

1. [Brain and blood single-cell transcriptomics in acute and subacute phases after stroke](https://www.nature.com/articles/s41590-023-01711-x) — Nature Immunology 2024
2. [Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke](https://pmc.ncbi.nlm.nih.gov/articles/PMC8721774/) — J Cereb Blood Flow Metab 2022
3. [Integrating spatial and single-cell transcriptomics of the ischemic mouse brain](https://www.science.org/doi/10.1126/scitranslmed.adg1323) — Science Translational Medicine 2023
4. [Multi-compartment single-cell transcriptomes redefine myeloid subtypes post-stroke](https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202408722) — Advanced Science 2025
5. [Circulating immune cell landscape in patients who had mild ischaemic stroke](https://pmc.ncbi.nlm.nih.gov/articles/PMC9453838/) — 2022
6. [CyTOF profiling identifies location-specific peripheral immune checkpoint in mild ischemic stroke](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1739324/full) — Frontiers in Immunology 2026
7. [Decoding immune cell dynamics in ischemic stroke: insights from scRNA-seq analysis](https://pmc.ncbi.nlm.nih.gov/articles/PMC12037566/) — 2025
8. [Uncovering dual roles of peripheral immune cells in stroke](https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2024.1443438/full) — Frontiers in Neuroscience 2024
9. [Integrating machine learning and single-cell transcriptomic analysis for IS biomarkers](https://www.nature.com/articles/s41598-024-77495-3) — Scientific Reports 2024
10. [Identification of key biomarkers in ischemic stroke: scRNAseq and WGCNA](https://www.aging-us.com/) — Aging 2023
11. [Multi-omics research strategies in ischemic stroke](https://www.sciencedirect.com/science/article/abs/pii/S1568163722001726) — Ageing Research Reviews 2022
12. [Single-cell omics: moving towards a new era in ischemic stroke research](https://www.sciencedirect.com/science/article/abs/pii/S0014299925004790) — European J Pharmacology 2025
13. [Deciphering the disease ecosystem of ischemic stroke via multi-omics](https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1740084/full) — Frontiers in Neuroscience 2026
14a. [CTSS-high monocytes aggravate cerebral ischemia-reperfusion injury](https://pubmed.ncbi.nlm.nih.gov/36371010/) — Brain Behav Immun 2023 (Xie et al.)
14b. [Monocyte/neutrophil/whole blood transcriptome dynamics following IS](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02766-1) — BMC Medicine 2023 (Carmona-Mora et al.)
14c. [Early peripheral blood gene expression and 90-day outcomes](https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-022-02680-y) — J Neuroinflammation 2023 (Amini et al.)
14d. [Single-cell analysis in cerebrovascular research](https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.049001) — Stroke 2024
14e. [Cell heterogeneity by scRNAseq offers targets for IS](https://www.aginganddisease.org/EN/10.14336/AD.2022.0212) — Aging and Disease 2022 (Qiu et al.)
14f. [Inflammation beneficial or detrimental in acute IS](https://onlinelibrary.wiley.com/doi/10.1111/cns.14510) — CNS Neurosci Ther 2024
14g. [scRNAseq review for stroke and TBI](https://journals.sagepub.com/doi/10.1177/0271678X241305914) — JCBFM 2024 (Shi et al.)

## Category 2: UK Biobank Proteomics & Mendelian Randomization

14. [Plasma proteomic associations with genetics and health in the UK Biobank (UKB-PPP)](https://www.nature.com/articles/s41586-023-06592-6) — Nature 2023 (Sun BB et al.)
15. [Large-Scale Plasma Proteomics Profiles for Predicting Ischemic Stroke Risk](https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.048654) — Stroke 2025 (Zhong et al.)
16. [A Proteomics-Based Approach for Prediction of CVD and Dementia](https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.070454) — Circulation 2025 (Ho et al.)
17. [Proteomics and the Risk of Incident Embolic and Thrombotic Stroke](https://onlinelibrary.wiley.com/doi/10.1002/ana.70011) — Annals of Neurology 2025 (Johansen et al.)
18. [Large-Scale Plasma Protein Profiling of Incident MI, IS, and HF](https://www.ahajournals.org/doi/10.1161/JAHA.121.023330) — JAHA 2021 (Lind et al.)
19. [Systematic MR using human plasma proteome for stroke targets](https://www.nature.com/articles/s41467-022-33675-1) — Nature Communications 2022 (Chong et al.)
20. [Novel Drug Targets for IS via MR of the Blood Proteome](https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.119.040180) — Circulation 2019 (Chong et al.)
21. [Proteome-Wide Genetic Study in East Asians and Europeans for IS Targets](https://www.ahajournals.org/doi/10.1161/STROKEAHA.125.050982) — Stroke 2025
22. [Protein Identification for Stroke Progression via MR in MVP and UKB](https://www.ahajournals.org/doi/10.1161/STROKEAHA.124.047103) — Stroke 2024
23. [Therapeutic targets for IS from plasma and CSF proteomes: multicenter MR](https://pmc.ncbi.nlm.nih.gov/articles/PMC10871597/) — International Journal of Surgery 2024 (Li et al.)
24. [Measured and genetically predicted protein levels and CVDs in UKB and CKB](https://www.nature.com/articles/s44161-024-00545-6) — Nature Cardiovascular Research 2024
25. [Serum Olink Proteomics-Based Identification of Immune Biomarkers in IS](https://pubs.acs.org/doi/10.1021/acs.jproteome.3c00885) — J Proteome Research 2024 (Li et al.)
26. [Divergent molecular signatures in IS and ICH](https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-025-00848-1) — Biomarker Research 2025 (Remon et al.)
27. [Blood protein assessment of leading diseases and mortality in UKB](https://www.nature.com/articles/s43587-024-00655-7) — Nature Aging 2024 (Gadd et al.)
28. [Interpretable ML leverages proteomics for CVD risk prediction](https://www.nature.com/articles/s43856-025-00872-0) — Communications Medicine 2025

## Category 3: Stroke Immunology & SIDS

29. [Immune responses to stroke: mechanisms, modulation, and therapeutic potential](https://pmc.ncbi.nlm.nih.gov/articles/PMC7260029/) — J Clin Invest 2020 (Iadecola et al.)
30. [The immunology of stroke: from mechanisms to translation](https://pmc.ncbi.nlm.nih.gov/articles/PMC3137275/) — Nature Medicine 2011 (Iadecola & Anrather)
31. [Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of IS](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.319994) — Circulation Research 2022 (Shi et al.)
32. [Stroke-induced immunosuppression: implications for prevention and prediction](https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-021-02177-0) — J Neuroinflammation 2021
33. [SIDS as predictor of functional outcome in neurorehabilitation](https://www.nature.com/articles/s41598-024-58562-1) — Scientific Reports 2024
34. [Analysis of lymphocyte subsets in patients with stroke and infection](https://www.ahajournals.org/doi/10.1161/strokeaha.107.493635) — Stroke 2008 (Vogelgesang et al.)
35. [Immunological consequences of ischemic stroke](https://pubmed.ncbi.nlm.nih.gov/23848237/) — 2013
36. [Clinical improvement reverses post-stroke cellular immune alterations](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.00414/full) — Frontiers in Neurology 2019
37. [Adaptive Immunity Regulation and Cerebral Ischemia](https://pmc.ncbi.nlm.nih.gov/articles/PMC7235404/) — 2020

## Category 4: Innate Immunity (Neutrophils, Monocytes, DAMPs)

38. [Role of Immune Cells Migrating to the Ischemic Brain](https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.021474) — Stroke
39. [Neutrophil Mobilization Triggers Microglial Change](https://advanced.onlinelibrary.wiley.com/doi/10.1002/advs.202503722) — Advanced Science 2025
40. [NET Content Impairs tPA-Induced Thrombolysis](https://www.ahajournals.org/doi/10.1161/STROKEAHA.117.019896) — Stroke
41. [The Role of Monocytes in Ischemic Stroke Pathobiology](https://pmc.ncbi.nlm.nih.gov/articles/PMC4761876/) — Frontiers
42. [Monocyte subtypes predict clinical course and prognosis](https://journals.sagepub.com/doi/pdf/10.1038/jcbfm.2009.25) — JCBFM 2009
43. [CD163 as potential biomarker of monocyte activation in IS](https://pmc.ncbi.nlm.nih.gov/articles/PMC8268853/) — 2021
44. [MAFB prevents excess inflammation after stroke](https://www.nature.com/articles/nm.4312) — Nature Medicine
45. [Monocytes are major players in prognosis and risk of infection](https://pubmed.ncbi.nlm.nih.gov/19164783/) — 2009
46. [HMGB1: New target for ischemic stroke](https://link.springer.com/article/10.1007/s12975-024-01258-5) — Transl Stroke Res 2024
47. [Danger signals in stroke and role on microglia activation](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968660/) — 2018
48. [DAMPs are locally released during occlusion in hyper-acute stroke](https://www.sciencedirect.com/science/article/pii/S2666354621000739) — 2021

## Category 5: Adaptive Immunity (T Cells, B Cells, NK Cells)

49. [Regulatory T Lymphocytes as Therapy for Ischemic Stroke](https://pmc.ncbi.nlm.nih.gov/articles/PMC10239790/) — 2023
50. [Gamma-delta T Cell in Cerebral Ischemic Stroke](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.842212/full) — Frontiers in Neurology 2022
51. [B-Lymphocyte-Mediated Delayed Cognitive Impairment Following Stroke](https://www.jneurosci.org/content/35/5/2133) — J Neurosci 2015 (Doyle et al.)
52. [Updates of the Role of B-cells in Ischemic Stroke](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2024.1340756/full) — Frontiers 2024
53. [Ischemic Neurons Recruit NK Cells That Accelerate Brain Infarction](https://www.pnas.org/doi/10.1073/pnas.1315943111) — PNAS
54. [Impact of NKG2D Signaling on NK and T-Cell Function in Cerebral Ischemia](https://www.ahajournals.org/doi/10.1161/JAHA.122.029529) — JAHA
55. [Circulating CD4+, CD8+, double-negative T cells in ischemic stroke](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1547905/full) — Frontiers 2025

## Category 6: Signaling Pathways

56. [Molecular mechanisms of inflammasome in IS pathogenesis](https://pmc.ncbi.nlm.nih.gov/articles/PMC9612213/) — 2022
57. [The NLRP3 Inflammasome in Ischemic Stroke](https://www.frontiersin.org/journals/stroke/articles/10.3389/fstro.2024.1382379/full) — Frontiers in Stroke 2024
58. [JAK inhibition ameliorates IS via JAK2/STAT3](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.714943/full) — Frontiers in Immunology 2021
59. [Significance of Complement System in Ischemic Stroke](https://pmc.ncbi.nlm.nih.gov/articles/PMC6457046/) — 2019
60. [Complex role of C3aR in cerebral injury and recovery](https://www.mdpi.com/2073-4409/14/18/1440) — 2025
61. [Complement C3 mediates inflammatory injury following focal cerebral ischemia](https://www.ahajournals.org/doi/10.1161/01.res.0000232544.90675.42) — Circ Res

## Category 7: EVT/Thrombectomy Biomarkers

62. [Follow-up NLR after stroke thrombectomy is independent biomarker](https://pubmed.ncbi.nlm.nih.gov/32763917/) — 2020
63. [Post-operative NLR and outcome after thrombectomy](https://pmc.ncbi.nlm.nih.gov/articles/PMC9554503/) — 2022
64. [NLR predicts intracranial hemorrhage after EVT](https://link.springer.com/article/10.1186/s12974-018-1359-2) — J Neuroinflammation
65. [Inflammatory biomarkers may be associated with poor outcomes after MT](https://thrombosisjournal.biomedcentral.com/articles/10.1186/s12959-024-00630-7) — Thrombosis Journal 2024
66. [Dynamic changes in inflammatory markers within 24 hours after MT](https://www.sciencedirect.com/science/article/pii/S0022510X25002047) — 2025

## Category 8: Clinical Immune Biomarkers (NLR, SII, MHR)

67. [NLR meta-analysis in stroke](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.686983/full) — Frontiers in Neurology 2021
68. [NLR as predictive biomarker for stroke severity](https://pmc.ncbi.nlm.nih.gov/articles/PMC8360230/) — 2021
69. [MHR predicts clinical outcomes after stroke or TIA](https://pubmed.ncbi.nlm.nih.gov/36914580/) — 2023
70. [MHR predicts the outcome of acute ischemic stroke](https://pmc.ncbi.nlm.nih.gov/articles/PMC7508725/) — 2020
71. [SII predictive value for adverse outcomes in stroke](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.836595/full) — Frontiers in Neurology 2022
72. [Comparison of SII and NLR for three-month outcome prediction](https://www.tandfonline.com/doi/full/10.1080/07853890.2026.2612820) — 2026
73. [Prognostic value of NLR, PLR, SII in acute ischemic stroke](https://pubmed.ncbi.nlm.nih.gov/34160404/) — 2021
74. [NLR as predictor of pneumonia and UTI after stroke](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.671739/full) — Frontiers 2021

## Category 9: Reviews & Frameworks

75. [Multilevel omics for biomarkers and therapeutic targets for stroke](https://www.nature.com/articles/s41582-020-0350-6) — Nature Reviews Neurology 2020 (Montaner et al.)
76. [Stroke Proteomics: From Discovery to Diagnostic and Therapeutic Applications](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.122.320110) — Circulation Research 2022 (Simats et al.)
77. [Biomarkers of immune capacity, infection and inflammation — PREDICT study](https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-019-1375-6) — BMC Neurology 2019
78. [Blood biomarkers for physical recovery in ischemic stroke](https://pmc.ncbi.nlm.nih.gov/articles/PMC6731415/) — 2019
79. [Novel inflammatory biomarkers associated with stroke severity](https://neurolrespract.biomedcentral.com/articles/10.1186/s42466-023-00259-3) — Neurol Res Practice 2023
80. [Expression of cytokines and chemokines as predictors of stroke outcomes](https://pubmed.ncbi.nlm.nih.gov/32010048/) — 2020
81. [Immunomodulation after ischemic stroke: potential mechanisms](https://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1573-1) — Critical Care 2016
82. [The local and peripheral immune responses to stroke](https://link.springer.com/article/10.1007/s13311-020-00844-3) — Neurotherapeutics 2020
83. [Systemic immune responses after ischemic stroke: from center to periphery](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.911661/full) — Frontiers in Immunology 2022
